Comments
Loading...

Imagin Medical Analyst Ratings

IMEXFOTCEM
Logo brought to you by Benzinga Data
$0.000001
At close: Jan 27, 10:17 AM EDT

Imagin Medical Analyst Ratings and Price Targets | OTC:IMEXF | Benzinga

Imagin Medical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Imagin Medical Corp from these most-recent analyst ratings.

Analyst Ratings for Imagin Medical

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for Imagin Medical (IMEXF) stock?

A

There is no price target for Imagin Medical

Q

What is the most recent analyst rating for Imagin Medical (IMEXF)?

A

There is no analyst for Imagin Medical

Q

When was the last upgrade for Imagin Medical (IMEXF)?

A

There is no last upgrade for Imagin Medical

Q

When was the last downgrade for Imagin Medical (IMEXF)?

A

There is no last downgrade for Imagin Medical.

Q

When is the next analyst rating going to be posted or updated for Imagin Medical (IMEXF)?

A

There is no next analyst rating for Imagin Medical.

Q

Is the Analyst Rating Imagin Medical (IMEXF) correct?

A

There is no next analyst rating for Imagin Medical.

Browse analyst ratings and price targets on all stocks.